Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac Left Atrial Evaluation and Response in HFrEF With Sacubitril/Valsartan: The CLEAR Study.

NCT07088471 is registered in ClinicalTrials.gov with Connolly Hospital Blanchardstown as lead sponsor.

NCT NCT07088471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07088471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac Left Atrial Evaluation and Response in HFrEF With Sacubitril/Valsartan: The CLEAR Study.
Lead sponsor
Connolly Hospital Blanchardstown
Phase
Observational
Overall status
Completed
Start date
November 1, 2024
Completion date
August 1, 2025
Enrollment
334 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure and reduced ejection fraction